NFG
WST icon

Nations Financial Group’s West Pharmaceutical WST Stock Holding History

Nations Financial Group’s Portfolio WST Stock Details WST Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2022
Q4 		– Sell
-6,172
Closed -$1.52M – 628
2022
Q3 		$1.52M Sell
6,172
-1,327
-18% -$404K 0.22% 109
2022
Q2 		$2.27M Buy
7,499
+205
+3% +$66.7K 0.3% 82
2022
Q1 		$3M Buy
7,294
+288
+4% +$113K 0.36% 61
2021
Q4 		$3.29M Buy
7,006
+219
+3% +$94.3K 0.43% 50
2021
Q3 		$2.88M Buy
6,787
+144
+2% +$60.7K 0.44% 46
2021
Q2 		$2.39M Buy
6,643
+417
+7% +$138K 0.4% 56
2021
Q1 		$1.75M Buy
6,226
+222
+4% +$63.5K 0.4% 57
2020
Q4 		$1.7M Buy
6,004
+1,373
+30% +$385K 0.45% 48
2020
Q3 		$1.27M Sell
4,631
-2,322
-33% -$614K 0.39% 63
2020
Q2 		$1.58M Sell
6,953
-142
-2% -$27.9K 0.56% 41
2020
Q1 		$1.08M Buy
7,095
+162
+2% +$24.9K 0.46% 56
2019
Q4 		$1.04M Buy
6,933
+28
+0.4% +$4.08K 0.36% 82
2019
Q3 		$993K Buy
+6,905
New +$951K 0.36% 79

Other funds holding WST

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.38T AUM 44.17% 1-Year Est. Return
APG Asset Management
APG Asset Management Amsterdam, Netherlands $40.7B AUM 39.97% 1-Year Est. Return
Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
T. Rowe Price Investment Management
T. Rowe Price Investment Management Baltimore, Maryland $153B AUM 38.14% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Nations Financial Group's WST Position: Q4 2022 in Review

Nations Financial Group sold out of West Pharmaceutical (WST) in Q4 2022, closing a stake of 6,172 shares — an estimated $1.52M sold.

Nations Financial Group first reported a position in WST in Q3 2019 and held it in 13 quarters. The position peaked at $3.29M in Q4 2021. 637 funds tracked by Wall St. Rank hold WST as of Q4 2022.

  • Nations Financial Group reported no remaining West Pharmaceutical position as of Q4 2022 after selling out during the quarter.
  • Nations Financial Group sold 6,172 West Pharmaceutical shares in Q4 2022, an estimated $1.52M.
  • Nations Financial Group first reported a position in West Pharmaceutical in Q3 2019 and held it in 13 quarters.
  • Nations Financial Group's West Pharmaceutical position peaked at $3.29M in Q4 2021.
  • 637 funds tracked by Wall St. Rank held West Pharmaceutical as of Q4 2022.

Based on Nations Financial Group's 13F filing for Q4 2022, filed 7 Feb 2023.